Two of President Trump’s top health nominees are on a collision course as the incoming administration faces a crucial ...

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI ...

【导读】超重和肥胖给个人和社会带来了严重的健康挑战。这项研究重点关注减肥药物对心脏代谢健康、心理结果和不良事件的影响，从而促进肥胖症的个性化治疗。2024年12月27日，中南大学湘雅二医院张晶晶教授团队在期刊《eClinicalMedicine》上发 ...

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Health Care Health Care   The Big Story MAHA leaders heading for clash over GLP-1 drugs Two of President-elect Trump’s top ...

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

Biopharmaceutical firms engaged in developing weight-loss drugs were rewarded rather significantly in 2024. It’s what helped ...

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...

The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...